Skip to main content

Cardinal Health Value Stock - Dividend - Research Selection

Cardinal health

ISIN: US14149Y1082 , WKN: 880206

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Cardinal Health, Inc. operates as an integrated healthcare services and products company worldwide. The company\'s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers. This segment also operates nuclear pharmacies and manufacturing facilities that manufacture, prepare, and deliver radiopharmaceuticals, as well as operates direct-to-patient specialty pharmacies; offers logistics, marketing, and other services; and repackages generic pharmaceuticals and over-the-counter healthcare products. The company\'s Medical segment manufactures and sources medical, surgical, and laboratory products, including cardiovascular and endovascular products; wound care products; surgical drapes, gowns, and apparel; exam and surgical gloves; fluid suction and collection systems; and incontinence, enteral feeding, urology, operating room supply, electrode and needle, and syringe and sharps disposal product lines. It also distributes medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers, as well as to patients in the home; and assembles and sells sterile and non-sterile procedure kits. In addition, it offers supply chain services to healthcare providers; and post-acute care management, and transition services and software to hospitals, other healthcare providers, and payers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 things this healthcare exec is aligned with the Trump admin. on

2026-02-07
Cardinal Health (CAH)CFO Aaron Alt sits down with Julie Hyman to speak more about the Trump administration's healthcare policies, especially as the Affordable Care Act (ACA, also known as Obamacare) subsidies expired at the end of 2025. Also catch Aaron Alt discuss the trends in healthcare demands as the American patient population continues to age. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Cardinal Health price target raised to $255 from $245 at Morgan Stanley

2026-02-07
Morgan Stanley raised the firm’s price target on Cardinal Health (CAH) to $255 from $245 and keeps an Overweight rating on the shares. The risk reward for Cardinal Health has been updated following the company’s “strong” Q2 results, the analyst tells investors in a research note.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Pu

Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade)

2026-02-07
Cardinal Health (CAH) upgraded to Buy after strong Q2 FY2026 results, higher guidance, and $750M buybacks. Read here for more analysis.

I think the CEO of FedEx has done an incredible job, says Jim Cramer

2026-02-06
CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.

Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates

2026-02-06
DOCS beats Q3 EPS and revenue estimates, but shares plunge 38.5% after hours as margins contract and FY26 revenue guidance is lowered.

Here's How Quest Diagnostics Is Placed Ahead of Q4 Earnings

2026-02-06
DGX heads into Q4 earnings with expected revenue and EPS growth, DIS momentum, and benefits from Fresenius assets and consumer testing.

Cardinal Health Q2 Earnings Call Highlights

2026-02-06
Cardinal Health (NYSE:CAH) reported fiscal second-quarter 2026 results that management described as “another excellent quarter,” citing broad-based momentum across the portfolio and double-digit profit growth in each of its five operating segments. Executives also raised full-year earnings guidance

Is Cardinal Health (CAH) Pricing Reflect Its Surge And Role In The Healthcare Supply Chain

2026-02-06
If you are looking at Cardinal Health and wondering whether the recent run has left the stock overpriced or still attractive, this article will walk through what the current price might be implying. The share price sits at US$227.18, with returns of 7.6% over 7 days, 9.0% over 30 days, 10.4% year to date and 81.1% over 1 year, and very large gains over 3 and 5 years. This naturally raises questions about how much value is already reflected. Recent news flow around Cardinal Health has focused...

CAH Q4 Deep Dive: Specialty and Growth Segments Drive Outperformance and Upgraded Outlook

2026-02-06
Healthcare distributor and services company Cardinal Health (NYSE:CAH) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 18.8% year on year to $65.63 billion. Its non-GAAP profit of $2.63 per share was 11.2% above analysts’ consensus estimates.

Cardinal Health Inc (CAH) Q2 2026 Earnings Call Highlights: Robust Revenue Growth and Raised ...

2026-02-05
Cardinal Health Inc (CAH) reports a 19% revenue increase and raises fiscal year 2026 EPS guidance, driven by strong performance across all segments.